Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

IP Group investee Apollo Therapeutics completes USD145 million raise

Thu, 17th Jun 2021 09:48

(Alliance News) - IP Group PLC on Thursday said its portfolio company Apollo Therapeutics Fund completed a USD145 million financing to further its pharmaceutical pipeline.

The London-based intellectual property businesses holds a minority stake in Apollo, which was added to its portfolio when it acquired Touchstone Innovations PLC. The recent financing leaves IP Group with an undiluted beneficial holding in Apollo of approximately 2%, currently valued at GBP3.5 million.

Apollo is a biopharmaceutical company founded in 2015 as a joint venture between AstraZeneca PLC, GlaxoSmithKline PLC and Johnson & Johnson, alongside the technology transfer offices of the University of Cambridge, University College London and Imperial College London.

The company said that Apollo will use the financing funds to further its pipeline of therapeutic programmes, based on leading British academic research, and expand its operations. This includes establishing a presence around Boston, Massachusetts, well-known for its higher education institutions.

IP Group noted that the raise was led by Patient Square Capital, which will take a controlling stake in the business. Investors including Rock Springs Capital, Reimagined Ventures and UCL Technology Fund also participated.

IP Group shares were trading down 1.4% at 115.20 pence each in London on Thursday morning.

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.